MOESM3 of Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

Zijun Y. Xu-Monette (Contributor)
Jianyong Li (Creator)
Y. Xia (Creator)
Beryl Crossley (Creator)
Robert D. Bremel (Creator)
Yi Miao (Creator)
Min Xiao (Creator)
Thomas Snyder (Creator)
Ganiraju C. Manyam (Contributor)
Xiaohong Tan (Contributor)
Hongwei Zhang (Contributor)
Carlo Visco (Creator)
Alexander Tzankov (Creator)
Karen Dybkær (Creator)
Govind Bhagat (Creator)
Wayne Tam (Creator)
Hua You (Creator)
Eric D. Hsi (Creator)
J. Han Van Krieken (Contributor)
Jooryung Huh (Contributor)
Maurilio Ponzoni (Creator)
Andrés J M Ferreri (Contributor)
Michael B. Møller (Contributor)
Miguel A. Piris (Creator)
Jane Norma Winter (Creator)
L. Jeffrey Medeiros (Creator)
Bing Xu (Creator)
Yong Li (Creator)
Ilan Kirsch (Creator)
Ken H. Young (Creator)

Dataset

Description

Additional file 3. Diagnostic immunoglobulin heavy chain gene sequences

Date made available	2019
Publisher	figshare

DOI
10.6084/m9.figshare.10027217.v1

Access Dataset

CC BY + CC0

1 Article

Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
Xu-Monette, Z. Y., Li, J., Xia, Y., Crossley, B., Bremel, R. D., Miao, Y., Xiao, M., Snyder, T., Manyam, G. C., Tan, X., Zhang, H., Visco, C., Tzankov, A., Dybkaer, K., Bhagat, G., Tam, W., You, H., Hsi, E. D., Van Krieken, J. H., Huh, J., & 10 othersPonzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Winter, J. N., Medeiros, J. T., Xu, B., Li, Y., Kirsch, I. & Young, K. H., Oct 22 2019, In: Journal for immunotherapy of cancer. 7, 1, 272.
Research output: Contribution to journal › Article › peer-review

Open Access
16 Scopus citations

Cite this

Xu-Monette, Z. Y. (Contributor), Li, J. (Creator), Xia, Y. (Creator), Crossley, B. (Creator), Bremel, R. D. (Creator), Miao, Y. (Creator), Xiao, M. (Creator), Snyder, T. (Creator), Manyam, G. C. (Contributor), Tan, X. (Contributor), Zhang, H. (Contributor), Visco, C. (Creator), Tzankov, A. (Creator), Dybkaer, K. (Creator), Bhagat, G. (Creator), Tam, W. (Creator), You, H. (Creator), Hsi, E. D. (Creator), Van Krieken, J. H. (Contributor), Huh, J. (Contributor), Ponzoni, M. (Creator), Ferreri, A. J. M. (Contributor), Møller, M. B. (Contributor), Piris, M. A. (Creator), Winter, J. N. (Creator), Medeiros, J. T. (Creator), Xu, B. (Creator), Li, Y. (Creator), Kirsch, I. (Creator), Young, K. H. (Creator) (2019). MOESM3 of Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies. figshare. 10.6084/m9.figshare.10027217.v1

MOESM3 of Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

Description

DOI

Access Dataset

Research output

Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

Cite this